Thomas Cole

12.7k total citations · 2 hit papers
64 papers, 9.7k citations indexed

About

Thomas Cole is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Thomas Cole has authored 64 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 16 papers in Cancer Research. Recurrent topics in Thomas Cole's work include Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Cancer, Lipids, and Metabolism (15 papers). Thomas Cole is often cited by papers focused on Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Cancer, Lipids, and Metabolism (15 papers). Thomas Cole collaborates with scholars based in United States, Germany and Canada. Thomas Cole's co-authors include Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, Barry R. Davis, Eugene Braunwald, Jean L. Rouleau, Lisa Brown, J. Wayne Warnica, John D. Rutherford and Chuan‐Chuan Wun and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Thomas Cole

64 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 5.7k citations Frank M. Sacks, Marc A. Pfeffer et al. New England Journal of Medicine profile →
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels

1998 721 citations Frank M. Sacks, Lemuel A. Moyé et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Cole United States	31	6.3k	3.6k	2.7k	1.7k	1.4k	64	9.7k
John C. LaRosa United States	39	6.8k 1.1×	4.7k 1.3×	3.4k 1.3×	2.0k 1.2×	1.5k 1.1×	120	11.4k
Charles L. Shear United States	35	6.3k 1.0×	4.1k 1.2×	2.4k 0.9×	1.4k 0.8×	1.6k 1.1×	71	9.7k
Christopher J. Packard United Kingdom	40	7.6k 1.2×	4.5k 1.3×	2.7k 1.0×	1.8k 1.1×	1.9k 1.3×	92	11.5k
T. A. Miettinen Finland	20	5.9k 0.9×	2.4k 0.7×	2.3k 0.9×	1.6k 1.0×	1.1k 0.8×	51	9.0k
Conrad B. Blum United States	31	7.2k 1.1×	4.2k 1.2×	3.3k 1.2×	2.5k 1.5×	1.5k 1.1×	53	12.5k
A R Lorimer United Kingdom	29	5.9k 0.9×	3.3k 0.9×	2.8k 1.0×	1.6k 1.0×	1.3k 0.9×	112	9.5k
Michael Clearfield United States	21	5.9k 0.9×	3.0k 0.8×	2.2k 0.8×	1.6k 1.0×	1.3k 0.9×	64	8.6k
J. Malcolm O. Arnold Canada	49	5.4k 0.9×	2.2k 0.6×	6.2k 2.3×	1.6k 1.0×	983 0.7×	102	13.5k
Maurizio Averna Italy	45	5.2k 0.8×	2.9k 0.8×	2.8k 1.0×	1.0k 0.6×	1.2k 0.9×	288	9.6k
Christopher Isles United Kingdom	10	4.9k 0.8×	2.3k 0.6×	1.8k 0.7×	1.6k 1.0×	951 0.7×	19	7.1k

Countries citing papers authored by Thomas Cole

Since Specialization

Citations

This map shows the geographic impact of Thomas Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cole more than expected).

Fields of papers citing papers by Thomas Cole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cole. The network helps show where Thomas Cole may publish in the future.

Co-authorship network of co-authors of Thomas Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Cole. A scholar is included among the top collaborators of Thomas Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Cole. Thomas Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cole, Thomas, et al.. (2024). Process intensification in reverse flow reactors to boost various industrial applications: A review. Chemical Engineering and Processing - Process Intensification. 208. 110097–110097. 1 indexed citations

Win, Zarni, Neva Patel, Rohini Sharma, et al.. (2021). Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines. Frontiers in Immunology. 11. 613496–613496. 7 indexed citations

Polage, Christopher R., Randie R. Little, Curt L. Rohlfing, Thomas Cole, & William L. Roberts. (2004). Effects of beta thalassemia minor on results of six glycated hemoglobin methods. Clinica Chimica Acta. 350(1-2). 123–128. 9 indexed citations

Nowatzke, William, et al.. (2004). Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark™) and determination of reference intervals on the Hitachi 917 analyzer. Clinica Chimica Acta. 350(1-2). 201–209. 42 indexed citations

Fagan, Anne M., et al.. (2000). Differences in the A?40/A?42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Annals of Neurology. 48(2). 201–210. 110 indexed citations

Wu, Alan H.B., John H. Contois, & Thomas Cole. (1999). Reflex testing I: Algorithm for lipid and lipoprotein measurement in coronary heart disease risk assessment. Clinica Chimica Acta. 280(1-2). 181–193. 6 indexed citations

Nauck, Matthias, Maria Stella Graziani, Jochen Jarausch, et al.. (1999). A New Liquid Homogeneous Assay for HDL Cholesterol Determination Evaluated in Seven Laboratories in Europe and the United States. Clinical Chemistry and Laboratory Medicine (CCLM). 37(11-12). 1067–1076. 12 indexed citations

Angelopoulos, Theodore J., Richard L. Seip, & Thomas Cole. (1998). Effect of Short-Term Recombinant Growth Hormone Administration on Plasma Lipoproteins in Elderly Adults. Gerontology. 44(4). 228–231. 10 indexed citations

Sacks, Frank M., Lemuel A. Moyé, Barry R. Davis, et al.. (1998). Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial. Circulation. 97(15). 1446–1452. 274 indexed citations

10.

Krul, Elaine S. & Thomas Cole. (1996). [10] Quantitation of apolipoprotein E. Methods in enzymology on CD-ROM/Methods in enzymology. 263. 170–187. 8 indexed citations

11.

Schaefer, Ernst J., Stefania Lamon‐Fava, Thomas Cole, et al.. (1996). Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Atherosclerosis. 127(1). 113–122. 12 indexed citations

12.

Sacks, Frank M., Marc A. Pfeffer, Lemuel A. Moyé, et al.. (1996). The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels. New England Journal of Medicine. 335(14). 1001–1009. 5701 indexed citations breakdown →

13.

Srivastava, Neelam, Davide Noto, Maurizio Averna, et al.. (1996). A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: Genetic and metabolic studies. Metabolism. 45(10). 1296–1304. 14 indexed citations

14.

Cole, Thomas, et al.. (1995). Apolipoprotein e genotyping methods for the clinical laboratory. Journal of Clinical Laboratory Analysis. 9(1). 63–69. 18 indexed citations

15.

Sacks, Frank M., Marc A. Pfeffer, Lemuel A. Moyé, et al.. (1991). Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE). The American Journal of Cardiology. 68(15). 1436–1446. 95 indexed citations

16.

Schmeisser, D, et al.. (1991). Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets. American Journal of Clinical Nutrition. 54(2). 304–310. 92 indexed citations

17.

Moberly, James B., Thomas Cole, David Alpers, & Gustav Schonfeld. (1990). Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1042(1). 70–80. 127 indexed citations

18.

Jiao, Sheng, Thomas Cole, Robert T. Kitchens, Barbara Pfleger, & Gustav Schonfeld. (1990). Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography. Metabolism. 39(2). 155–160. 123 indexed citations

19.

Cole, Thomas, et al.. (1983). Increases in Dietary Cholesterol and Fat Raise Levels of Apoprotein E-Containing Lipdproteins in the Plasma of Man*. The Journal of Clinical Endocrinology & Metabolism. 56(6). 1108–1115. 23 indexed citations

20.

Cole, Thomas & Murray Heimberg. (1979). Modulation of hepatic tri glyceride and ketone body output by dexamethasone. Clinical research. 27(4). 715. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact